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Introduction
Cancer is the most common cause of disease-related
death in children in Hong Kong. Advances in surgical
techniques, radiotherapy, chemotherapy, and hema-
topoietic stem cell transplantation (HSCT) have led
to major improvements in survival and cure rates for
many types of childhood malignant disease. Similar to
other western countries, leukemia is the most common
form of childhood cancer (40%) for local children younger
than 15 years followed by brain tumor (16%) 1. A recent
review showed that the overall cure rate of childhood
malignancies now exceeds 70% and is projected to reach
85% by the year 2010 2.
Dentists encounter many common complications of
cancer therapy, such as oral mucositis and xerostomia.
Cancer therapy induces damage to the mucosal barrier of
the oral cavity that is thus susceptible to inflammation
and consequent erythema, ulceration, erosion, and
pseudomembrane formation (otherwise known as oral
mucositis).
Oral mucositis is a frequent complication of cancer
chemotherapy and can occur anywhere along the digestive
tract, from the mouth to the anus. Chemotherapeutic
agents that affect rapidly growing tumor cells also affect
rapidly growing normal tissue, such as the oral mucosa,
gastric and intestinal mucosa, and conjunctival tissue 3.
They slow down the maturation of rapidly dividing
cells and break down and thin the protective epithelial
lining, thus rendering it susceptible to irritation,
inflammation, and infection. The past decade has witness-
ed an increased understanding of the specific biological
complexities that underlie mucosal barrier injury, and
in particular, oral mucositis. Our understanding of
the molecular, cellular, and tissue events that lead to
this common and often dose-limiting toxicity continue
to evolve. To aid with understanding of oral mucosal
injury, a model with five phases was proposed: initiation,
up-regulation with generation of messengers, signaling
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ABSTRACT Objectives. To investigate the orofacial complications in children undergoing cancer therapy and
to increase their awareness of oral health. Methods. A randomly selected convenient sample of 46 children aged below
18 years undergoing combination chemotherapy for hematological malignancies or solid tumors at Queen Mary Hospital
were recruited. Clinical examination and a parental questionnaire survey were performed. Parents were taught about
oral health and received a talk that focused on the common oral complications of cancer therapy and their management.
Results. Oral mucositis presenting as erythema or ulceration, mostly on the buccal mucosa, was present in approximately
one third of children. Many had dry and cracked lips with varying degrees of xerostomia. Oral hygiene was generally
unsatisfactory, although the majority brushed their teeth and 60% rinsed their mouth with antiseptics. The prevalence of
opportunistic infection was nonetheless very low. Only one child presented with acute pseudomembranous candidiasis
and none had herpes simplex infection. Most parents or caretakers reported that their children experienced pain in the
mouth during cancer therapy. Many reported that their children had difficulty in speaking, pain while swallowing,
salivary changes, and a dry mouth. Other oral complications included alteration of taste, bad breath, bleeding gums,
and tooth decay. Conclusion. Oral mucositis was a common complication during cancer therapy together with pain in
the oral cavity, poor oral hygiene, and dental caries. Professional oral care should be mandatory before, during, and
after cancer therapy.
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and amplification, ulceration with inflammation, and
finally healing 4.
During the course of cancer therapy, patients are
immunosuppressed due to myelosuppression. Oral
opportunistic infections, such as herpes simplex and
candidiasis are anticipated complications. In addition,
graft-versus-host disease (GVHD), while rare, can be a
serious life-threatening consequence of allogenic
HSCT. Oral signs and symptoms can present either in
the early phase (less than 100 days after the transplant) or
later on with a varying degree of severity. It carries
significant prognostic value for the underlying GVHD.
Radiotherapy, especially to the orofacial region, can
induce oral mucositis and other complications, such as
xerostomia (often irreversible), trismus, and osteonecrosis.
These may in turn cause functional disturbances, such as
difficulty in speaking, mastication and swallowing, and
eventually lead to nutritional deficiency.
Data on orofacial complications among Hong Kong
Chinese population are few. To rectify this, and as part of
a community dental health project, a group of fourth-year
dental students investigated the orofacial complications in
children undergoing cancer therapy in one of the tertiary
care institutions in Hong Kong 5,6. They also intended to
increase the awareness of children and their carers of
the importance of oral health.
Methods
The study was carried out over 2 weeks in March 2004 in
a children’s ward in the Department of Paediatrics and
Adolescent Medicine, Queen Mary Hospital, Hong Kong.
A randomly selected sample of 46 children aged below
18 years undergoing combination chemotherapy for
hematological malignancies or solid tumors were
recruited. A clinical oral assessment of the participating
children was performed and a questionnaire survey
among their parents or caretakers conducted. Informed
consent was obtained from all parents or caretakers prior
to the clinical examination.
The questionnaire consisted of nine simple closed
questions designed to assess the dental habits of children
and the parents’ or caretakers’ attitudes toward dental
health. A dental student and one of the authors were
present to clarify the questions if necessary and to ensure
the questionnaire was correctly completed.
Two pairs of dental students conducted the oral
examinations separately under the supervision of the
authors. The examination included a general physical
examination of the head and neck region, followed by a
clinical examination of the dentition and oral soft
tissues using dental mirrors and a portable light source.
Clinical assessment was performed using two commonly
used scoring tools, the Oral Assessment Guide 7 and the
Oral Mucositis Assessment Scale 8. Clinical examination
was intended to reveal: (1) presence of dental caries; (2)
presence of dental plaque; (3) presence of infection, such
as herpes and candidiasis; (4) thrombocytopathy in
the form of oral petechiae and spontaneous gingival
bleeding; and (5) mucositis. Clinical findings were
always discussed and individual oral health instructions
were given to the children and their caretakers. An oral
health education talk was held for the children, parents,
caretakers, and the nurses. It focused on the common
oral complications of cancer therapy, their management,
dietary modification, and the prevention and management
of tooth decay.
Results
A total of 46 children participated in this study: 30 (65%)
boys and 16 (35%) girls with a mean age of 9.4 years
(standard deviation, 4.8 years). Of these, 11 (24%) were
currently undergoing treatment and 35 (76%) were in
remission. The children had leukemia (57%), a tumor of
the nervous tissue (26%), or a solid tumor such as
rhabdomyosarcoma and liver cancer (17%).
Approximately one third (15/46, 33%) of the children
had oral mucositis presenting as erythema (6/15, 40%),
ulceration (5/15, 33%), or both (4/15, 27%). The most
frequently affected site was the buccal mucosa (85%).
Other affected sites included the tongue, floor of the
mouth, and the palate or lips. Five (11%) children had
oral petechiae but their platelet counts were unavailable
at the time of examination. Ten (22%) had dry and cracked
lips and a varying degree of xerostomia. One child had
exacerbated chronic GVHD and her entire oral cavity
and lips were affected by severe mucositis associated
with trismus and lichenoid changes. The prevalence of
opportunistic infection was very low: only one child had
oral pseudomembranous candidiasis and none had oral
herpes simplex at the time of study.
The oral hygiene of these children was generally
unsatisfactory with localized plaque (12/46, 26%) and
generalized plaque (13/46, 28%). Nonetheless most
(30/46, 65%) brushed their teeth at least once a day. Two
reported being unable to brush their teeth. Most (69%)
of the participants did not use dental floss and only 40%
used mouthwash. Most importantly, 14 (30%) children
had one or more untreated carious teeth, and a few had a
dental abscess.
Twenty-five (54%) parents or caretakers reported that
their children experienced pain in the oral cavity during
Chu et al
104    Hong Kong Dent J Vol 2 No 2 December 2005
cancer therapy. Twenty-one (46%) reported difficulty in
speaking and swallowing. Dry mouth (31%), alteration of
taste (27%), bad breath (22%), and bleeding gums
(16%) were also reported. Only 13 (28%) parents or
caretakers took their children for regular dental check-
ups at least once a year, while 42% never visited a
dentist on a regular basis. Twenty-six (57%) children ate a
snack at least once a day and 10 (22%) never consumed
snacks between meals.
If the child complained of toothache, most parents or
caretakers (82%) preferred to bring their children to a
dentist. Only a few (3/46, 7%) opted for nonprescription
painkillers and some (3/46, 7%) advised their children
simply to ignore the pain.
Discussion
The prevalence of oral complications, especially oral
mucositis in children undergoing cancer therapy was
similar to that reported by studies from the West 9,10. The
incidence and prevalence of oral tissue injury varies
depending on the diagnosis and treatment regimens 4.
The time course of oral mucositis is well researched, and
is generally around 3 weeks. It begins 3 to 5 days follow-
ing commencement of cancer therapy, and peaks at 7 to
14 days 11. This project was a single time-point cross-
sectional study of a randomly selected sample of children
with cancer. The changes in oral cavity experienced by
the children during their active treatment in the hospital
might differ to those observed during ambulatory or
follow-up care. In the latter, oral lesions may have healed
before the clinical examination. A limitation of this study
was that neither the day of onset nor resolution could be
specified. In addition, it was not possible to accurately record
the response of the oral mucosal membrane to intervention.
All children reported oral disturbances caused by cancer
therapy, such as pain, dry mouth, bad breath (halitosis),
tooth decay, bleeding gums, altered taste, and problems with
speech and swallowing. Pain, the most frequent complaint,
led to dysphagia with a consequent decreased oral intake
that resulted in poor nutrition and dehydration. Pain could
also cause therapy to be interrupted, prolong hospital stay
and thus increase the cost of treatment. Pain may also have
interfered with plaque control. Mouthwashes that contain
local anesthetic and antiseptic (e.g. Difflam; 3M
Pharmaceuticals, Thornleigh, Australia) and systemic
analgesics (e.g. Panadol; GlaxoSmithKline, Middlesex,
United Kingdom) were frequently used to alleviate pain.
Frequent rinsing with sodium chloride solution or normal
saline was recommended to keep the mucosa moist and to
soothe inflamed or ulcerated mucosa.
Many of the children who presented with oral
mucositis also had generalized or localized plaque
and debris. In such children, oral debridement should
be performed with caution because there is often
concomitant neutropenia and thrombocytopenia, thus
traumatic tooth brushing can cause gingival bleeding
and, more importantly, result in transient bacteremia.
Ultra-soft toothbrushes, such as Butler Ultra-soft
Toothbrush (John O Butler Co., Chicago, United States)
and Biotene Supersoft Brush (Laclede, Inc., California,
United States), should be used for mechanical cleaning of
teeth. Sponge-tipped applicators and gauze soaked in
sodium chloride solution are recommended for oral
debridement. Antiseptic and alcohol-free mouthwashes
should be used to reduce the oral bacterial load.
All dental treatment should be completed before
cancer therapy and a high standard of oral hygiene
maintained throughout treatment and hospital stay.
Many local children received no dental treatment before
or during cancer therapy. Furthermore, parental awareness
of the importance of proper dental care in relation to
cancer therapy was generally poor. It is thus imperative
to encourage parents’ and caretakers’ awareness of oral
health and for oral health to be monitored before
commencing therapy. In addition, ongoing prevention
of caries and a high standard of oral care should be
provided during and after cancer therapy and during
remission by a dentist experienced in the care of cancer
patients.
The 1990 National Institutes of Health Consensus Panel
stated that to minimize oral complications, all cancer
patients should have an oral examination and pre-
existing oral disease should be treated before cancer
therapy is initiated 12. Oral complications from cancer
therapy not only hamper the patient’s quality of life but
may cause further potentially life-threatening complica-
tions such as septicemia. The dentist must work together
with the medical team to help prevent and manage any
oral problems.
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